Chinese Journal of Pharmaceuticals
|
2025, 56(7): 965-969
The Operation Dilemmas, Cause Analysis and Institutional Improvement of the Market Exclusivity Period System for First Generic Drugs in China
Full
- 1.Civil, Commercial and Economic Law School, China University of Political Science and Law, Beijing 100088
- 2.BrightGene Bio-Medical Technology Co., Ltd., Suzhou 215123
- 3.School of Pharmacutical Sciences, Wuhan University, Wuhan 430071
- 4.School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205
- 5.School of Law, Humanities and Society, Wuhan University of Technology, Wuhan 430070
- 6.Law and Business School of Wuhan Instiute of Technology (School of Intellectual Property), Wuhan 430205
- 7.Coherent Biopharma (suzhou) Co., Ltd., Suzhou 215123
冯向阳, 黄璐, 柳洋洋.
我国首仿药市场独占期制度的运行困境、原因分析及制度完善.
中国医药工业杂志,
2025
, 56
(7)
: 965
-969
.
DOI: 10.16522/j.cnki.cjph.2025.07.017
Xiangyang FENG, Lu HUANG, Yangyang LIU.
The Operation Dilemmas, Cause Analysis and Institutional Improvement of the Market Exclusivity Period System for First Generic Drugs in China[J].
Chinese Journal of Pharmaceuticals,
2025
, 56
(7)
: 965
-969
.
DOI: 10.16522/j.cnki.cjph.2025.07.017